A CAR T-cell therapy program at SinoUnited Health in Shanghai, for international patients, including those from Australia, New Zealand and Southeast Asia. More than 100 international patients assessed and over 30 treated with CAR T-cell therapy across the past two years.
Watch: inside the CAR-T program (2 min)A dedicated CAR-T program with a published hematologist as Chief of Hematology, within one of China's leading hematology research networks.
Chief of Hematology · Chief Physician · SinoUnited Health
Dr. Zhou is Chief of Hematology for the CAR T-cell therapy program at SinoUnited Health. She completed her postdoctoral fellowship at the University of California, San Francisco (UCSF), has practiced clinical hematology for more than twenty years, and has published 25 publications indexed in PubMed.
An English-speaking care manager guides international patients from first contact to discharge.
Patients' cells are collected at the hospital on a Terumo Spectra Optia apheresis system.
Five intensive care units, five operating theaters — two Class 100 laminar-flow.
SinoUnited Health is a member unit of the Shanghai Ruijin Consortium of Blood Disease.
Dr. Zhou’s program is backed by a multidisciplinary inpatient care team spanning critical care, neurology, respiratory and internal medicine.
Meet the full medical team
Dr. Hua ShenInternal medicine
Dr. George LuEmergency & critical care
Dr. Lynne ZhangNeurology
Dr. Louisa LongGeneral & internal medicine
Dr. Min XuGastroenterology
Dr. Yanyan ChenRespiratory & critical care
The right pathway depends on your diagnosis. Find your condition below — each page sets out the approved indication in full.
Eight CAR T-cell therapies approved by China's NMPA — seven developed in China. Explore the therapies
Treatment happens across two trips to Shanghai. We're upfront about the time it takes, because planning around it matters.
Start a free remote assessment; SinoUnited Health's team reviews your records and tells you whether CAR T-cell therapy may be an option — before you travel, at no cost.
Remote · no costIn-person assessment and cell collection. You may return home while your cells are prepared, if your condition allows.
Assessment + collectionCells are manufactured over three to four weeks; you return for conditioning, infusion, and a supervised inpatient stay.
Manufacturing 3–4 weeksThe complete journey is typically around two months, across two visits to Shanghai.
See the full patient journey →Stories from patients who have traveled to Shanghai for CAR T-cell therapy — with video and photography, recorded with their consent, in their own words.
Emma
A chef from Gisborne who had run out of options at home, and the community that rallied to get her to Shanghai.
Read Emma's story
Irene
When her lymphoma relapsed less than a year after chemotherapy, Irene was on the ground in Shanghai within a week.
Read Irene's story
Dale
An Auckland construction manager whose lymphoma didn't respond to chemotherapy, and the choice he faced.
Read Dale's storyEvery patient's journey is unique. The experiences described here are personal accounts and are not a prediction of results for anyone else.
CAR T-cell therapy at SinoUnited Health is a single, all-inclusive package. SinoUnited Health puts it at around one-third of what comparable treatment typically costs in the West — its own comparison; no figures are published, and your package cost is confirmed individually.
Assessment before you travel is free, and your deposit is fully refundable† — less the cost of any tests already completed — if cell collection doesn't proceed.
See what's included →The name describes the two hospital stays it covers.
Start a free remote assessment by SinoUnited Health's international care team. You'll hear back within 24 hours.
Inside the CAR-T program · Dr. Lily Zhou and SinoUnited Health leadership · 2 min